Related Experiment Video

Updated: May 27, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Use of natriuretic peptides to guide and monitor heart failure therapy

A Mark Richards1, Richard W Troughton

  • 1Department of Medicine, University of Otago, Christchurch School of Medicine, Christchurch Hospital, Christchurch, New Zealand. mdcarthu@nus.edu.sg

Clinical Chemistry
|November 17, 2011
PubMed

Insights

Serial B-type peptide measurements can guide heart failure treatment. Adjusting therapy based on these peptide levels may reduce cardiac mortality and hospitalizations in select patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Management

Background:

  • Plasma B-type natriuretic peptides indicate cardiac health and prognosis.
  • Decreases in these peptides correlate with positive treatment responses in heart failure.
  • This suggests intensifying treatment to lower peptide levels may improve outcomes.

Purpose of the Study:

  • To review randomized controlled trials on using serial B-type peptide measurements to guide chronic heart failure therapy.
  • To assess the efficacy of this approach in improving patient outcomes.

Main Methods:

  • Systematic review and meta-analysis of published randomized controlled trials since 2000.
  • Analysis of trial designs, patient populations, follow-up durations, and endpoint data.
  • Evaluation of studies where B-type peptide levels were used to titrate heart failure medications and devices.

Main Results:

  • Consistent evidence suggests benefits from using serial B-type peptide measurements to guide therapy.
  • Two meta-analyses support the emerging consistency of these findings.
  • Improvements in outcomes were observed, though specific mediating mechanisms require further clarification.

Conclusions:

  • Adjusting chronic heart failure treatment using serial B-type peptide measurements alongside clinical methods is likely beneficial.
  • This approach may reduce cardiac mortality and hospital admissions.
  • The benefits are most suggested for younger patients (<75 years) with systolic heart failure and fewer comorbidities.
Abstract

More Related Videos

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models07:49

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Published on: July 21, 2023

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...